Vasopressin Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: Vasopressin evidence and protocol review

Signal Peptides peptide Injection solutionLyophilizedLyophilized research material verified

Also known as: Arginine vasopressin, AVP

Open in Calculator ← Compound Index All Tools

Quick Facts

Reference Sizes

20 units/mL single-dose vial, 200 units/10 mL multidose vial, 40 units/100 mL premixed bag, 60 units/100 mL premixed bag, 1 mg RUO vial; mass-to-unit conversion is product-specific

Calculator

Preset available

Storage

Per clinical product labeling: refrigerate - verify current label/COA for research-grade material.

Solubility

Aqueous injectable solution; lyophilized research form

Catalog Description

Vasopressin (antidiuretic hormone, ADH) is an endogenous peptide hormone regulating renal water reabsorption (via V2 receptors) and vascular tone (via V1 receptors), with clinical use in diabetes insipidus and vasodilatory shock. It is also studied alongside oxytocin as a 'social neuropeptide,' with research addressing the neurogenetics of sociality and translational applications of both peptides in the human brain.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life

~10-35 minutes

Onset

Acute effects on water reabsorption/vascular tone within minutes of dosing

Administration Routes (Research)

Reported Research Effects

Regulates renal water reabsorption (antidiuretic effect)
Regulates vascular tone (vasopressor effect)
Studied alongside oxytocin in social-neuropeptide/pair-bonding research

Reported Research Side Effects

Cardiac ischemia
Mesenteric or digital ischemia
Hyponatremia or water intoxication
Decreased cardiac output
Arrhythmia
Skin necrosis with extravasation

Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Septic shock: start 0.01 units/min and titrate by 0.005 units/min at 10-15 minute intervals to 0.07 units/min [IV infusion; Acute critical care; Continuous]Source: VASOSTRICT prescribing information

Research Notes

Current U.S. products express vasopressin potency in units, not milligrams. Do not infer a mass-to-unit conversion for a 1 mg RUO vial without a product-specific potency assay.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

VASOSTRICT vasopressin prescribing information — DailyMed (NIH)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b97e5c3e-ca28-4ffa-80af-6c5bdbadaf10

Vasopressin injection and premixed presentations — DailyMed (NIH)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d162d386-105d-e916-e053-2995a90a350c

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Reconstitution CalculatorConcentration, draw volume, per-unit amounts Unit Convertermg, mcg, mL, units conversion Compound CompareSide-by-side comparison tool Cost CalculatorCost per mg, mcg, per-draw

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.